Literature DB >> 12658687

Microemulsion electrokinetic chromatography applied for separation of levetiracetam from other antiepileptic drugs in polypharmacy.

Mariela Ivanova1, Alessandra Piunti, Ettore Marziali, Natalja Komarova, Maria Augusta Raggi, Ernst Kenndler.   

Abstract

Microemulsion electrokinetic chromatography was applied for the separation of levetiracetam from other antiepileptic drugs (primidone, phenobarbital, phenytoin, lamotrigine and carbamazepine) that are potentially coadministered in therapy of patients. The influence of the composition of the microemulsion system (with sodium dodecyl sulfate as charged surfactant) was investigated, modifying the kind of cosurfactant (lower alcohols from C3 to C5), the pH (and salinity) of the aqueous background electrolyte, and the ratio of aqueous phase to organic constituents forming the microdroplets of the oil-in-water emulsion. Separation selectivity was depending on all these parameters, resulting even in changes of the migration sequence of the analytes. Only moderate correlation was observed for the microemulsion system compared with a micellar system, both consisting of the aqueous borate buffer (pH 9.2) and SDS as micelle former (linear correlation coefficient for analyte mobilities is 0.974). The sample solvent plays an important role on the shape of the resulting chromatograms: methanol at concentrations higher than 35% impairs peak shape and separation efficiency. The microemulsion method (with 93.76% aqueous borate buffer (pH 9.2, 10 mM), 0.48% n-octane, 1.80% SDS, 3.96% 1-butanol, all w/w) is suitable for the determination of levetiracetam in human plasma (combined with a sample pretreatment based on solid-phase extraction).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12658687     DOI: 10.1002/elps.200390143

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  4 in total

1.  Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications.

Authors:  Matthew D Krasowski
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-11

Review 2.  Clinical pharmacokinetics of levetiracetam.

Authors:  Philip N Patsalos
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Rapid and simultaneous quantification of levetiracetam and its carboxylic metabolite in human plasma by liquid chromatography tandem mass spectrometry.

Authors:  Li-Ling Yeap; Yoke-Lin Lo
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

4.  Chromatographic Characterization and Method Development for Determination of Levetiracetam in Saliva: Application to Correlation with Plasma Levels.

Authors:  Imad I Hamdan; Mervat Alsous; Amira Taher Masri
Journal:  J Anal Methods Chem       Date:  2017-08-07       Impact factor: 2.193

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.